๐ฐ Johnm Leonard News
Johnm Leonard News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Johnm Leonard. Real-time updates on events, politics, business and more.
February 29, 2024
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report)’s stock price traded up 11.3% during trading on Tuesday . The company traded as high as $31.13 and last traded at $30.79. 2,174,127 shares changed hands during trading, an increase of 39% from the average session volume of 1,563,047 shares. The stock had previously closed at $27.66. […]
February 25, 2024
Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) issued its earnings results on Thursday. The company reported ($1.46) earnings per share for the quarter, topping the consensus estimate of ($1.47) by $0.01, Briefing.com reports. Intellia Therapeutics had a negative return on equity of 43.31% and a negative net margin of 893.34%. The business had revenue of […]
February 23, 2024
Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) posted its earnings results on Thursday. The company reported ($1.46) EPS for the quarter, topping the consensus estimate of ($1.47) by $0.01, Briefing.com reports. Intellia Therapeutics had a negative net margin of 893.34% and a negative return on equity of 40.49%. The firm had revenue of ($1.92) million […]
February 22, 2024
Aigen Investment Management LP purchased a new stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 17,569 shares of the company’s stock, valued at approximately $556,000. Other institutional investors have also made changes to […]
January 26, 2024
Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) have earned an average rating of “Moderate Buy” from the eighteen research firms that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and fifteen have assigned a buy recommendation to the company. The average twelve-month […]
January 24, 2024
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) has earned an average rating of “Moderate Buy” from the eighteen brokerages that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average 12 month price objective […]
January 11, 2024
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Equities researchers at Brookline Capital Management raised their FY2025 earnings per share estimates for shares of Intellia Therapeutics in a research report issued on Sunday, January 7th. Brookline Capital Management analyst L. Cann now forecasts that the company will post earnings of ($5.12) per share for the […]
November 11, 2023
The massacre of Israeli civilians by Hamas on October 7 cannot be seen as anything other than a terrible war crime, and the taking into Gaza of civilian hostages, including children, is indefensible.
August 6, 2023
I agree with John M Leonard that the portrait of Dr Noel Browne should be on display in Leinster House (โBallaghโs portrait of Dr Browne deserves pride of place in Leinster Houseโ, Letters, August 4). Watching the recent documentary on the man, it seems clear he was at times hung out to dry by the establishment of the time.
March 29, 2023
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Rating) – Analysts at William Blair issued their Q1 2023 EPS estimates for shares of Intellia Therapeutics in a research report issued to clients and investors on Wednesday, March 22nd. William Blair analyst M. Minter forecasts that the company will post earnings of ($1.42) per share for the quarter. […]